11 
Federal, State, and local activities bearing on the regulation of 
recombinant DNA research. Among Congressional proposals reviewed were 
Senate Bill 621, "The DNA Research Act of 1977," introduced by Senator 
Dale Bumpers, and the companion measure introduced by Representative 
Richard L. Ottinger in the House (H.R. 3591). The Committee also noted 
the resolution introduced by Representative Ottinger on January 19, 1977 
(H. Res. 131), requesting DHEW to regulate recombinant DNA research under 
Section 361 of the PHS Act. 
Hearings held by State and local governments, including State legis- 
latures, were among State and local activities reviewed. Recommendations 
by the New York State Attorney General's Environmental Health Bureau for 
State regulation, and by the Cambridge (Massachusetts) City Council for 
city regulation, were also considered. 
Several committee representatives also reported on meetings with 
other interested parties whose views had been solicited on legislation 
to regulate recombinant DNA research. Those who were contacted include 
agricultural scientists, biomedical scientists, environmentalists, labor 
unions, and private industry. At my request, the Industrial Research 
Institute and the Pharmaceutical Manufacturers Association are surveying 
their member firms to determine the scope of the research efforts in the 
private sector. The Pharmaceutical Manufacturers Association has adopted 
the NIH Guidelines as standards for conduct of this research. 
[ 837 ] 
